Assessment of the effect of implementation of global initiatives for asthma (GINA) guidelines in the outcome of asthma exacerbation in the emergency department  by Mourad, Sahar Taher et al.
Egyptian Journal of Chest Diseases and Tuberculosis (2012) 61, 257–273The Egyptian Society of Chest Diseases and Tuberculosis
Egyptian Journal of Chest Diseases and Tuberculosis
www.elsevier.com/locate/ejcdt
www.sciencedirect.comORIGINAL ARTICLEAssessment of the eﬀect of implementation of global
initiatives for asthma (GINA) guidelines in the outcome
of asthma exacerbation in the emergency departmentSahar Taher Mourad a, Anwar Ahmed Elganady a, Enas Elsayed Mohamed a,*,
Ahmed Mostafa Elgammal ba Chest Diseases Department, Faculty of Medicine, Alexandria University, Egypt
b Emergency Department, Al-Amrya Hospital, EgyptReceived 8 September 2012; accepted 20 September 2012
Available online 23 January 2013*
E-
Pe
D
04
OpKEYWORDS
Asthma;
Peak expiratory ﬂow (PEF);
Pulse oximetry;
Treatment;
Global initiative for asthma
(GINA) guidelines;
Emergency department
(ED);
Asthma exacerbationCorresponding author. Tel.:
mail address: enas_elsayed73
er review under responsibil
iseases and Tuberculosis.
Production an
22-7638 ª 2012 The Egyptia
en access under CC BY-NC-ND li+20 122
@yahoo
ity of Th
d hostin
n Society
httpcense.Abstract Introduction: Asthma is a continuous signiﬁcant health problem. Strategies for treating
exacerbations are best adapted and implemented at a local level. Severe exacerbations are poten-
tially life threatening, and their treatment requires close supervision. The severity of the exacerba-
tion determines the treatment administered. Indices of severity, particularly peak expiratory ﬂow
(PEF), pulse rate, respiratory rate, and pulse oximetry should be monitored during treatment.
Aim of the work: The aim of this work was to assess the effect of the implementation of the Glo-
bal Initiative for Asthma (GINA) guidelines in the prognosis and the outcome of asthma exacerba-
tion in the emergency department.
Subjects and methods: The study was conducted on one hundred asthmatic patients. All patients
were informed about the study and gave their consents. Patients were subjected to full history tak-
ing and clinical evaluation. Investigations were done in the form of peak ﬂow rate (PFR) measure-
ment, pulse oximetry assessment, ABG analysis (for only 17 patients), chest X-ray (it is not
routinely recommended) and complete blood count (if needed). Then patients were classiﬁed
according to their attacks. All patients were managed according to GINA guidelines.
Results: Older patients were signiﬁcantly suffering from severe to life threatening attacks than
younger patients. We found that 12% of patients had occupational related asthma in relation to
88% of patients had non-occupational related asthma. There were no statistical signiﬁcant differ-
ences between classiﬁcation of severity of current attack and previous emergency department
(ED) visits/year. There were no statistical signiﬁcant differences between the studied groups4474317.
.com (E.E. Mohamed).
e Egyptian Society of Chest
g by Elsevier
of Chest Diseases and Tuberculosis. Production and hosting by Elsevier B.V.
://dx.doi.org/10.1016/j.ejcdt.2012.09.001
258 S.T. Mourad et al.regarding temperature. Systolic and diastolic blood pressure had statistically signiﬁcant lower val-
ues in patients with severe to life threatening attacks than those with mild to moderate attacks.
Severe to life threatening group had respiratory rate higher than mild to moderate group. Mild
to moderate group had PEF and SaO2% higher than severe to life threatening group. PEF was sta-
tistically higher post treatment than pre treatment. Three patients of 17 had PaCo2 >45 mmHg
with hypoxemia and respiratory acidosis and they admitted to the intensive care unit (ICU). All
patients in ED were assisted to determine the severity of asthma concomitant with administration
of initial treatment (plan A), which is oxygen to achieve O2 saturationP92%, inhaled B2 adrener-
gic bronchodilator and an oral or intravenous dose of corticosteroids. Five patients met a good
response so they enter in (plan C1). Seventy-ﬁve patients met with the criteria of moderate episode
they go to plan B1, 68 patients of them (about 90%) had a good response within 2 h so go to plan
C1 and the rest 7 patients (10%) had an incomplete response go to plan C2. Twenty patients met
with criteria of severe episode, 17 of them (85%) with incomplete response move to plan C2, and the
rest 3 patients (15%) had a poor response and moved to plan C3, no improvement noticed so they
were admitted to the ICU. Hospitalization was done to 11 patients who met a poor response (plan
C2), 86 patients were discharged from the ED (73 patients from plan C1 and 13 patients from plan
C2). Severe to life threatening group stayed in ED longer than mild to moderate group.
Conclusions and recommendations: All patients presenting in the emergency department with
asthma exacerbations should be evaluated and triaged immediately and must be treated according
to their severity of classiﬁcation using GINA guidelines. Measurements of airﬂow obstruction,
using peak expiratory ﬂow, can help to guide therapy for acute asthma. Continuous monitoring
of oxyhaemoglobin saturation by pulse oximetry should be undertaken for all patients with acute
exacerbation of asthma. We must; educate patients in ED about the nature of asthma and its ther-
apy, educate patients how to use inhalers, encourage patients to use spirometer at home and dis-
charge each patient with ED-asthma discharge plan.
ª 2012 The Egyptian Society of Chest Diseases and Tuberculosis. Production and hosting by Elsevier B.V.
Open access under CC BY-NC-ND license.Introduction
Asthma is a common chronic disorder of the airways that in-
volves a complex interaction of airﬂow obstruction, bronchial
hyper responsiveness and underlying inﬂammation. The inter-
action of these features of asthma determines the clinical man-
ifestations and severity of asthma and response to treatment.
This interaction can be highly variable among patients and
within patients over time [1].
Asthma is a continuous signiﬁcant health problem. The cost
of asthma care and the burden on individuals and society are
growing [2]. Factors that inﬂuence the risk of asthma can be
divided into those that cause the development of asthma and
those that trigger asthma symptoms; some do both. The for-
mer include host factors (which are primarily genetic) and
the latter are usually environmental factors [3]. Much of what
is known about asthma risk factors comes from studies of
young children. Risk factors for the development of asthma
in adult, particularly de novo in adults who did not have asth-
ma in childhood, are less well deﬁned [4–5].
The diagnosis of asthma is based on the recognition of
characteristics pattern of symptoms and signs and the absence
of an alternative explanation for them. The key is to take a
careful clinical history. If asthma does appear likely, the his-
tory should also explore possible causes, particularly occupa-
tional [6]. Spirometry, is the recommended method of
measuring airﬂow limitation and reversibility to establish a
diagnosis of asthma. Peak expiratory ﬂow (PEF), measure-
ments using a peak ﬂow meter is an important aid in both
diagnosis and monitoring of asthma. The differential diagnosis
in patients with suspected asthma differs among different age
groups: infants, children, young adults, and the elderly [7].Exacerbations of asthma (asthma attacks or acute asthma)
are episodes of progressive increase in shortness of breath,
cough, wheezing, or chest tightness, or some combination of
these symptoms. Exacerbations usually have a progressive on-
set but a subset of patients present more acutely [8].
Most patients suffering from acute asthma request therapy
with a constellation of complaints consisting of dyspnea,
cough, and wheezing. The ﬁrst two can also occur as isolated
entities. No signs or symptoms are uniformly present. The
physical signs that are encountered are tachypnea, tachycardia,
wheezes, hyperinﬂation, accessory muscle use, pulsus paradox-
us, diaphoresis and cyanosis [9].
Strategies for treating exacerbations are best adapted and
implemented at a local level. Severe exacerbations are poten-
tially life threatening and their treatment requires close
supervision. Patients with severe exacerbations should be
encouraged to see their physician promptly or, depending
on the organization of local health service, to proceed to
the nearest clinic or hospital that provides emergency access
for patients with acute asthma. Close objective monitoring
of the response to therapy is essential by measuring PEF.
The severity of the exacerbation determines the treatment
administered. Indices of severity, particularly PEF, pulse rate,
respiratory rate, and pulse oximetry should be monitored
during treatment [7]. Partial pressure of carbon dioxide
(PaCO2) may worsen in some patients on 65 percent oxygen,
especially those with more severe airﬂow obstruction. Oxygen
therapy should be titrated against pulse oximetry to maintain
satisfactory oxygen saturation [10]. It is very essential to as-
sess the likelihood of asthma-related hospitalizations or emer-
gency department (ED) visits in adults with severe or difﬁcult
to treat asthma [11].
Assessment of the effect of implementation of global initiatives for asthma (GINA) 259The primary therapies for exacerbations include-in the
order in which they are introduced, depending on severity-
repetitive administration of rapid-acting inhaled bronchodila-
tors, early introduction of systemic glucocorticoides, and
oxygen supplementation. The aims of treatment are to relieve
airﬂow obstruction and hypoxemia as quickly as possible, and
to prevent of future relapses [7].
Aim of the work
General objectives
The aim of this work was to assess the effect of the implemen-
tation of the Global Initiative for Asthma (GINA) guidelines
in the prognosis and the outcome of asthma exacerbation in
the emergency department.
Speciﬁc objectives1. To assess the severity of acute asthma exacerbation.
2. Implement the new guidelines in the treatment of acute
asthma exacerbation.
3. Assess the outcome of the patients.
4. Give each patient emergency department asthma discharge
plan.Subjects and methods
The study was conducted on one hundred asthmatic patients
attending Alexandria University Hospital and Alamrya Gener-
al Hospital. All patients were informed about the study and
gave their consents.
Exclusion criteria1. Patients with other causes of airﬂow limitation (e.g. chronic
bronchitis).
2. Patients younger than 16 years.
3. Patients suffering from severe chronic malignancies and
other fatal disease.
All the patients were subjected to the following:
(1) History taking:– Age, sex and occupation.
– Smoking history.
– Potential causes of exacerbation (allergy, infection,
occupational, tobacco, diet, stress, drugs, others).
– Estimated numbers of previous emergency depart-
ment (ED) visits and hospitalizations for asthma in
the preceding year.
– Severity of symptoms especially compared with pre-
vious attacks.
– Current medical treatment.
– Co morbidities.
– Family history.(2) Clinical examination:Figure 1 Mini-Wright peak ﬂow meter.– Vital signs: (blood pressure, respiratory rate, pulse
rate, temperature).
– Symptoms (breathlessness, inability to talk and
alertness).– Signs (use of accessory muscles, wheezes, level of
consciousness).(3) Investigations:– Assessment of lung function by using a Mini-Wright
peak ﬂow meter (Fig. 1). Peak ﬂow rate measurement
depended signiﬁcantly on patient effort and techni-
que. Therefore, clear instructions, demonstrations,
and frequent review of technique were essential. Then
calculation of the predicted (peak expiratory ﬂow r-
ate) PEFR for each patient was done using the equ-
ation as shown in Fig. 2.
– Pulse oximetry: To determine adequacy of oxygen
therapy and the need for arterial blood gas (ABG)
measurement (the aim of oxygen therapy is to mai-
ntain SaO2 94–98%).
– Blood gases (ABG): ABG was measured using rapid
lab-248 Ph blood gas Analyzer of payer UK. Patients
with SpO2 <92% (irrespective of whether the patient
is on room air or oxygen) or other features of life t-
hreatening asthma require ABG measurement. SpO2
<92% is associated with a risk of hypercapnea. H-
ypercapnea is not detected by pulse oximetry.
– Chest X-ray:It is not routinely recommended in pa-
tients in absence of:
 Suspected pneumomediastinum or
pneumothorax.
 Suspected consolidation.
 Life threatening asthma.
 Failure to respond to treatment.
 Requirement for ventilation.
– Complete blood count was done if needed
(4) Then patients were classiﬁed as follows [7].
(5) All the patients were managed according to (Tables 2
and 3) GINA guidelines [7].
(6) Every patient should have emergency department
asthma discharge plan [9].Statistical analysis
The clinical and laboratory results were statistically analyzed
using SPSS/PC (Statistical package for social science for perso-
nal computers).
Figure 2 Peak expiratory ﬂow rate-normal values [6].
Table 1 Classiﬁcation of exacerbation severity.
Mild Moderate Severe Respiratory arrest
imminent
Breathless Walking
Can lie down
Talking
Prefer sitting
At rest
Hunched
forward
Talks in Sentences Phrases Words
Alertness May be agitated Usually agitated Usually
agitated
Drowsy or confused
Respiratory rate Increased Increased Often >30/
min
Accessory muscles and
suprasternal retraction
Usually not Usually Usually Paradoxical thoraco
abdominal movement
Wheeze Moderate often only end
expiratory
Loud Usually loud Absence of wheeze
Pulse/min <100 100–120 >120 Bradycardia
Pulsus paradoxus Absent <10 mm hg May be present
10–25 mm hg
Often present
>25 mm hg
Absent (suggests
respiratory muscle
fatigue)
PEF
After initial
Bronchodilator
%predicted or
%personal best
>80% 60–80% <60%
predicted
Or personal
best
(<100 L/min)
Or response
last <
PaO2(on air)
and/or
PaCO2
Normal (test not usually
Necessary) <45 mm hg
>60 mm Hg
<45 mm Hg
<60 mm
Hg Possible
cyanosis
>45 mm Hg
Possible
respiratory
failure
SaO2% (on air) >95% 91–95% 690%
*Note: the presence of several parameters, but not necessarily all, indicates the general classiﬁcation of the exacerbation.
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Table 2 Management of asthma exacerbations in emergency department.
Assessment of the effect of implementation of global initiatives for asthma (GINA) 261Results
This study was conducted on one hundred asthmatic patients,
the distribution of the patients according to severity of currentattack showed that, 80 patients (80%) presented with mild to
moderate attacks and 20 patients (20%) presented with severe
to life threatening attacks.
Table 3 Emergency department asthma discharge plan (that was given to each patient in English to be ﬁlled by the physician and
translated after its discussion with the patient).
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Table 4 Cross tabulation between severity of current attack
and age of the patients.
Min. Max. Mean S.D. T Sig.
Age
Mild to moderate 18 70 36.30 12.134 8.562 .004*
Sever to life threatening 33 57 44.65 7.741
* Statistically signiﬁcant.
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and age of the patients, it illustrated that, older patients were
signiﬁcantly suffering (Tables 5 and 7) from severe to life
threatening attacks than younger patients (P= 0.004).
The relation between severity of current attack and sex
demonstrated that, mild to moderate attacks were found in
54% of female patients and 46% of male patients, while severe
to life threatening attacks were found in 65% of female pa-
tients and 35% of male patients. There was no signiﬁcant dif-
ference between our classiﬁcations regarding sex (P= 0.258).
We found that, 12% of patients had occupational related asth-
ma and 88% of patients had non-occupational related asthma.
There were only 10 patients with history of mild active smok-
ing and their pack year index ranged between 2 and 7 pack/
year.Table 5 Relation between severity of current attack and previous E
Min. Max.
Previous ED visits/year
Mild to moderate 1 144
Sever to life threatening 1 96
Table 6 Relation between severity of current attack and blood pre
Min. Max.
Systolic
Mild to moderate 12 150
Sever to life threatening 80 120
Diastolic
Mild to moderate 70 100
Sever to life threatening 60 80
* Statistically signiﬁcant.
Table 7 Relation between severity of current attack and respirator
Min. Max.
Respiratory rate
Mild to moderate 18 25
Sever to life threatening 24 41
PEF%
Mild to moderate 55 81
Sever to life threatening 55 60
SaO2%
Mild to moderate 92 98
Sever to life threatening 80 94
* Statistically signiﬁcant.Other types of allergy were found in 14 subjects (14.0%)
who were evaluated by history. These other allergies were rhi-
nitis, sinusitis and nasal polyps.
There was no statistical signiﬁcant difference between the
classiﬁcation of severity of current attack and previous ED vis-
its/year (P= 0.870).
We found by the history (without documentations) that
44% of patients used inhaled short acting B2 agonist, 47%
used inhaled corticosteroids with different doses, 33% used
theophylline, 27% used oral short acting B2 agonist, 9% used
long acting B2 agonist, 3% used cromones and 6% used leuko-
trien modiﬁers (Fig. 3). There was no statistical signiﬁcant dif-
ference between classiﬁcation of asthma exacerbation and
current treatment.
In the present study there were 10% of patients had some
co morbidities like gastro esophageal reﬂux and chest infec-
tion. However, there was no signiﬁcant difference between
classiﬁcation of asthma exacerbation and presence of co
morbidities.
Family history of asthma and other atopic conditions were
present in 43% of patients with no signiﬁcant difference be-
tween family history of atopy and severity of current attack
(P= 0.291).
The relation between severity of (Figs. 4–7) current attack
and temperature showed that, the mean of temperature wasD visits/year.
Mean S.D. T Sig.
21.28 30.488 .027 .870
19.88 27.950
ssure.
Mean S.D. t Sig.
115.71 13.463 27.696 .0001*
98.50 11.367
74.94 5.926 40.250 .0001*
65.50 6.048
y rate, PEF and SaO2 %.
Mean S.D. t Sig.
21.93 1.777 163.649 .0001*
30.35 4.760
69.15 7.328 19.740 .0001*
58.22 1.394
95.60 1.411 133.691 .0001*
89.20 4.124
Figure 3 The relation between severity of current attack and the current treatment.
Figure 4 Distribution of patients according to their clinical and physiological parameters.
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Figure 5 Peak expiratory ﬂow measurements before and after implementation of GINA guidelines in relation to severity of current
attack.
Figure 6 The relation between the severity of current attack and the different treatment plans.
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vere to life threatening attack groups, respectively. There was
no statistical signiﬁcant difference between the studied groups
regarding temperature (P= 0.064).
Table 6 showed that systolic blood pressure had statistically
signiﬁcant lower values in patients with severe to life threaten-
ing attacks than those with mild to moderate attacks
(P= 0.0001). Also diastolic blood pressure had statistically
signiﬁcant lower values in patients with severe to life threaten-
ing attacks than those with mild to moderate attacks.
(P= 0.0001).
The peak expiratory ﬂow measurements before and after
implementation of GINA guidelines were presented in Table
8, the mean values of PEF were 68.04 ± 7.70 and80.0 ± 8.68 pre and post implementation of GINA guidelines,
respectively. PEF was (Tables 9–15) statistically higher post
treatment than pre treatment (P= 0.001).
Arterial blood gases evaluation was done to17 patients (only
three patients had PaCo2 more than 45 mmHg with hypoxemia
and respiratory acidosis) while plain X-ray chest P-A view was
done to 14 patients with no signiﬁcant ﬁndings and complete
blood count was done to 3 patients with no speciﬁc ﬁndings.
Relation between severity of current attack and duration of
stay in ED in hours were presented in Table 16, it showed that,
the mean duration of stay in ED (hours) was 2.25 ± 1.037 and
5.38 ± 2.605 h for mild to moderate and severe to life threat-
ening groups respectively. Severe group (Tables 17 and 18)
stayed in ED longer duration than mild group. (P= 0.0001).
Figure 7 Patient pathway during implementation of GINA guidelines.
Table 8 The peak expiratory ﬂow measurements before and
after implementation of GINA guidelines.
Pre treatment PEF% Post treatment PEF%
Min. 55 65.00
Max 81 96.00
Mean 68.04 80.0000
S.D. 7.705 8.68122
T 6.98
P 0.001*
* Statistically signiﬁcant.
266 S.T. Mourad et al.Discussion
Clinical guidelines are systematically designed to help practi-
tioners and patients make decisions regarding the appropriate
health care for speciﬁc circumstances [12].Table 9 The frequency of patients according to severity of current
Severity of current attack
Mild to moderate
Treatment Plan A
Receive 80
% 100.0%
Table 10 The frequency of patients according to severity of curren
Crosstab Severity of curren
Mild to moderate
Treatment Plan B1
Did not receive No. 7
% 8.75%
Receive No. 73
% 91.25%
Total No. 80
% 100.0%
X2 56.33
P .000In this study, the susceptibility of older patient to severe to
life threatening asthma exacerbation may be due to other co
morbidities and use of multiple drugs that affect the airways.
This was similar with the ﬁndings of Hartert et al [13] who said
that older patients were suffering from severe life threatening
asthma attacks.
In this study, there were no statistical signiﬁcant differences
between severity of current attack and the sex. Tattersﬁeld et al
[14]; showed that female sex was associated with an increased
risk of severe exacerbation but Raherison et al [15]; found that
there was no difference in asthma severity between men and
women. British guidelines demonstrated that the male sex is
a risk factor for asthma in pre pubertal children and female
sex is a risk factor for the persistence of asthma in transition
from childhood to adulthood [6].
The distribution of the patients according to the occupation
was 12% occupational related asthma in relation to 88% non-
occupational related asthma. Le Moual, et al [16] stated that
there is a strong deleterious role of occupation in severe asth-attack receiving plan A.
Total
Severe to life threatening
20 100
100.0% 100.00%
t attack receiving plan B1.
t attack Total
Severe to life threatening
18 25
90% 25.0%
2 75
10% 75.0%
20 100
100.0% 100.0%
Table 11 The frequency of patients according to severity of current attack receiving plan B2.
Severity of current attack Total
Mild to moderate Severe to life threatening
Treatment Plan B2
Did not receive No. 78 2 80
% 97.5% 10.0% 80.0%
Receive No. 2 18 20
% 2.5% 90.0% 20.0%
Total No. 80 20 100
% 100.0% 100.0% 100.0%
X2 76.56
P .000
Table 12 The frequency of patients according to severity of current attack receiving plan C1.
Severity of current attack Total
Mild to moderate Severe to life threatening
Treatment Plan c1
Did not receive No. 11 16 27
% 13% 100.0% 27.0%
Receive No. 73 0 73
% 87% .0% 73.0%
Total No. 84 16 100
% 100.0% 100.0% 100.0%
X2 51.50
P .000
Table 13 The frequency of patients according to severity of current attack receiving plan C2.
Severity of current attack Total
Mild to moderate Severe to life threatening
Treatment Plan C2
Did not receive No. 73 3 76
% 91.25% 15.0% 76.0%
Receive No. 7 17 24
% 8.75% 85.0% 24.0%
Total No. 80 20 100
% 100.0% 100.0% 100.0%
X2 51.00
P .000
Table 14 The frequency of patients according to severity of current attack receiving plan C3.
Severity of current attack Total
Mild to moderate Severe to life threatening
Treatment Plan C3
Did not receive No. 80 17 97
% 100.0% 85.0% 97.0%
Rceive No. 0 3 3
% .0% 15.0% 3.0%
Total No. 80 20 100
% 100.0% 100.0% 100.0%
X2 12.37
P .0004
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Table 15 The frequency of patients according to severity of current attack receiving plan D.
Severity of current attack Total
Mild to moderate Severe to life threatening
Treatment Plan D
Receive No. 60 26 86
% 69.8% 30.2% 100.0%
Table 16 Relation between severity of current attack and duration of stay in ED in hours.
Min. Max. Mean S.D. T Sig.
Duration of stay in ED in hours Mild to moderate 1 5 2.25 1.037 71.575 .0001*
Sever to life threatening 1 8 5.38 2.605
* Statistically signiﬁcant.
Table 17 Distribution of the patients according to hospital
admission in days.
Frequency Percent
Not admitted 89 89.0
Admitted for one day 3 3.0
Admitted for two days 5 5.0
Admitted for 5 days 3 3.0
Total 100 100.0
268 S.T. Mourad et al.ma, and clinician should consider occupational exposures in-
patient with moderate to severe asthma.
In our study asthma, exacerbations were caused by a vari-
ety of factors; including allergen, infection, occupational sensi-
tizers, tobacco, stress and drugs.
Cates et al [17] stated that the upper respiratory tract infec-
tion was the commonest type of infection and the researcher
found that patient with moderate to severe asthma should be
advised to receive an inﬂuenza vaccination every year. How-
ever, routine inﬂuenza vaccination of children and adults does
not appear to protect them from asthma exacerbation or im-
prove the asthma control.
Mark et al [18] stated that exposure to tobacco is associated
with greater asthma severity, worse health status and increase
health care utilization in adults with asthma. Thompson et al
[19] found that in addition to increasing asthma symptoms
and causing long-term impairment in lung function; active cig-
arette smoking reduces the efﬁcacy of inhaled and systemicTable 18 Cross tabulation between ICU admission and severity of
Number of days Severity of curren
Mild to moderate
ICU admission
0 No. 80
% 100.0%
1 No. 0
% .0%
Total No. 80
% 100.0%
X2 12.371
P .007glucocorticoides, and smoking cessation needs to be vigorously
encouraged for all patients with asthma who smoke.
Nagel et al [20] said that some evidence suggests correlation
between consumption of certain food and development of
allergies and asthma. Diets rich in fruits and vegetables might
prevent asthma symptoms, where ingestion of saturated fats
might contribute to atopic diseases.
Nouwen, et al [21] stated that emotional stress might lead to
asthma exacerbations because extreme emotional expressions
(laughing, crying, anger and fear) can lead to hyperventilation
and hypocapnea, which can cause airway narrowing. Chetta
et al [22] also stated that several psychological factors had been
shown to be related to poor asthma control and severe asthma
attack.
The only drug in our study that caused exacerbation was
angiotensin converting enzyme (ACE) inhibitor; the appear-
ance of only one drug as a trigger factor for the exacerbation
may be due to limited number of patients in the present study.
A study done by Covar et al [23] there was evidence that
some drugs as ACE inhibitors and other non-steroidal anti-
inﬂammatory drugs cause severe asthma exacerbations and
should be avoided.
Similarly, a longitudinal population study about rhinitis
and onset of asthma done by Shaaban et al [24] showed that
rhinitis frequently precedes asthma and is considered a risk
factor for development of asthma; more over it is associated
with increased severity of asthma. In addition, both acute
and chronic sinusitis can worsen asthma.current attack.
t attack Total
Severe to life threatening
17 97
85.0% 97.0%
3 3
15.0% 3.0%
20 100
100.0% 100.0%
Assessment of the effect of implementation of global initiatives for asthma (GINA) 269There were no statistical signiﬁcant differences between
classiﬁcation of severity of current attack and previous ED vis-
its/year (P= 0.870).
In the present study the relation between previous ED visits
and severity of asthma attacks was depending on history tak-
ing because of lack of documentation. Turner, et al [25] said
that patient with history of near fatal asthma receiving intuba-
tion and mechanical ventilation and patients who have had
hospitalization or emergency care visits in the past year were
considered as a high-risk group of asthma related death. Those
patients should be encouraged to seek urgent care early in the
course of their exacerbation and required close attention.
Multiple visits of emergency department in our study were
matching with other study which was done by Ford et al [26]
which showed that in 12 months prior to patients interview,
(82%) of patients visited the ED for asthma two or more times
with a mean of 8.5 visits, and (18%) visited ED once. In this
study they inquired about whether frequent ED use is related
to psychological or environmental factors, or to more severe
disease and more asthma exacerbation that require ED inter-
vention. This suggests that frequent ED use represent a group
of patients with more severe, poorly managed asthma. Simi-
larly, Farber et al [27] found that young patients visiting ED
had poorly managed and poorly controlled chronic asthma.
The goal of asthma treatment includes not only control of
clinical manifestation but also control of expected future risk
to the patients such as exacerbations, accelerated decline in
lung function and side effects of treatment [28].
In our study we found by the history (without documenta-
tions) that 44% of patients used inhaled short acting B2 ago-
nist, 47% used inhaled corticosteroids with different doses,
33% used theophylline, 27% used oral short acting B2 agonist,
9% used long acting B2 agonist, 3% used cromones and 6%
used leukotrien modiﬁers.
There was no statistical signiﬁcant difference between clas-
siﬁcation of asthma exacerbation and current treatment. In the
present study, history demonstrated poor adherence with asth-
ma medications also there was ignorance in the difference be-
tween reliever and controller medications, which made asthma
treatment inappropriate and lead to exacerbation.
Many studies proved that poor adherence to medications,
under use of inhaled corticosteroids, excessive or increasing
reliance on short acting B2 agonist bronchodilators, increase
in the use of oral theophylline and monotherapy with long act-
ing B2 agonist all of which are risk factors for development of
asthma exacerbation [29–31].
There was no signiﬁcant difference between the classiﬁca-
tion of asthma exacerbation and presence of co morbidities.
Similar to our study Harding SM [32] proved that the relation-
ship between increasing asthma symptoms and gastro esopha-
geal reﬂux remains uncertain. Although this condition is nearly
three times as prevalent in patients with asthma compared to
the general population.
Also Gem [33], found that respiratory infection have an
important relation to asthma as they provoke wheezing and in-
crease symptoms in many patients, and focused that the infec-
tious microorganisms associated with increased asthma
symptoms are often respiratory viruses.
In the present study family history of asthma and other ato-
pic conditions were present in 43% of patients with no signif-
icant difference between family history of atopy and severity of
current attack (P= 0.291). Also in British guideline in man-agement of asthma, family history of asthma and/or atopic dis-
order is not associated with increase in asthma severity [6].
A brief history and physical examination during exacerba-
tion should be conducted concurrently with the prompt initia-
tion of therapy. The physical examination should assess
exacerbation severity by evaluating pulse rate, respiratory rate,
use of accessory muscle, the ability to complete the sentences
and other parameters signs detailed in Table 1.
In our study the clinical and physiological parameters
helped us to assess the severity of current attack although no
signs or symptoms were uniformly present as wheezing was ab-
sent in about 5% of patients.
Wheezing is a poor indicator of functional impairment; it
often increases as the obstruction resolves and the patient’s
ability to move air improve. In addition, clinical experience
indicates that the combination of high-pitched wheezing with
poor air movement is associated with marked bronchial
narrowing.
Twenty percent of our patients were having pulse rate
>120 beats/min and they were in severe attacks. Rick et al
[34] proved that increasing heart rate is closely correlated with
increasing severity of asthma and it is incorrect to assume that
tachycardia is caused by use of B2 adrenergic bronchodilators.
In the present study, the use of accessory muscles was
observed in 30% of cases at presentation. Pulsus paradoxus
measurement was difﬁcult in ED circumstances. Inability to
communicate in full sentences and the degree of the breathless-
ness were associated with the airway narrowing.
Jay et al [35], found that although pulsus paradoxus and the
use of accessory muscles may correlate with the degree of
obstruction, it can be diminished as the patient becomes fati-
gued and lose ability to generate strong inspiratory effort so;
measurement of pulsus paradoxus is difﬁcult in ED and of lim-
ited prognostic use. So it is critical to appreciate that the ab-
sence of such signs does not guarantee an insigniﬁcant
episode and it is well established that patient with marked
bronchial narrowing can have minimal symptoms.
There were no statistical signiﬁcant differences between the
studied groups regarding relation between temperature and the
classiﬁcation of severity of current attack (p= 0.064). This re-
sults need to be supported by more other studies as there are
deﬁcient studies related to these variables and the severity of
asthma exacerbation. The increase in temperature was mainly
due to infection (respiratory infection). This exacerbated asth-
ma attack but we could not determine its effect on the severity
of it. In the study which done by Kraft [36] showed that respi-
ratory infection, in particularly viral in origin induced asthma
exacerbation, however, bacterial, including atypical, had also
been linked to asthma exacerbation, in particular when sinus-
itis is present.
The relation between severity of current attack and blood
pressure illustrated that severe to life threatening group had
systolic blood pressure lower than mild to moderate group.
(P= 0.0001). In addition, severe to life threatening group
had diastolic blood pressure lower than mild to moderate
group. (P= 0.0001). Therefore, we should put in our consid-
eration to treat hypotension concurrent with asthma treatment
during the management of severe attack.
The objective of the brief physical examination was to as-
sess both the severity of the exacerbation and over all patient
status, so in our study we focused on signs and symptoms that
indicate a potentially fatal asthma and we found that respira-
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mild to moderate. (P= 0.0001). This indicate that patient pre-
sented with respiratory rate >25/min should be assessed
quickly to determine whether the patient had any signs or
symptoms of potentially fatal asthma and should be immedi-
ately triaged to a closely monitored setting with the emergency
department. This is matching with what was found by Rick
et al [34] as the effective and efﬁcient treatment of acute asth-
ma in emergency department requires prompt recognition of
signs and symptoms that indicate a potentially fatal asthma at-
tack. One of these signs is increasing in respiratory rate >25–
30/min and patients meeting these criteria should be monitored
in ED for at least 1–2 h after arrival.
Both patients and physicians tend to inaccurately gauge the
level of airﬂow obstruction, which can lead to under treatment
and hence an unacceptable risk of relapse [37].
So assessment of lung function by using PEF performed at
presentation and again after 30–60 min after treatment is very
useful in categorizing severity of exacerbation and indicating
the need for hospitalization [38].
In our study measurement of lung function using PEF was
performed to almost all patients at the time of presentation ex-
cept to patients who were too ill to use the peak ﬂow meter. We
found that the mean of PEF before treatment was higher in
mild to moderate group than severe to life threatening group
(P= 0.0001). PEF was statistically higher post treatment than
pretreatment (P= 0.001). Therefore, PEF helped us in the
assessment of the patients and determined the severity of exac-
erbations and therefore the plan of treatment and the destina-
tion of the patient regarding admission to hospital or discharge
from ED.
Peak expiratory ﬂow is an integral component of the Cana-
dian triage and Acuity scale 2009; reliable and valid com-
plained-based triage tool developed by Canadian emergency
nurses and physicians to prioritize the severity of patient’s con-
dition and the timing of care in ED. They showed that mea-
surement of airﬂow obstruction can guide therapy for acute
asthma but are generally underutilized, despite their ease of
performance [39].
Aldington and Beasly [40] found that peak expiratory ﬂow
less than 30% of predicted at any time during an exacerbation
of asthma indicates a high degree of obstruction and suggest
the presence of elevated partial pressure of carbon dioxide
(PCO2) and the potential for fatigue of respiratory muscles
and the patient should be observed in acute care setting.
In this study the mean oxygen saturation monitored by
pulse oximetry illustrated that mild to moderate group had
oxygen saturation higher than severe to life threatening group;
so oxygen saturation should be continuously monitored by
pulse oximetry at the time of presentation and during treat-
ment. There were no problems with whom their oxygen satura-
tion values above 90%.
Rick et al [34] said that oxygen saturation should be contin-
uously monitored by pulse oximetry because cyanosis is a late
sign reﬂecting severe hypoxemia. For several reasons oximetry
is generally preferred over arterial blood gas analysis to assess
oxygenation as, oximetry provides real-time continuous mea-
surements, where blood gases are monitored only intermit-
tently and samples take time to be processed. Oximetry is
much easier to perform and painless to the patient.
To obtain reliable readings, the oximeter must be placed at
well-perfuse site and the pulse recorded by the oximeter shouldmatch the patient’s pulse determined manually. Pulse oxime-
ters may not provide reliable data for patients with global
hypo perfusion or peripheral vasoconstriction or in rare cases
in which carboxyheamoglobenemia or methemoglobenemia is
a possibility. Therefore, in the setting of acute asthma, deter-
mining arterial blood gases is a must if there are no oximetry
data or if the data are thought to be unreliable [41]. Although
arterial blood gases analysis is rarely needed for optimum
management of acute asthma, it is necessary to patients with
a pre treatment oxygen saturation of less than 90%, any one
in whom the saturation falls during observation and those
who’s PEFR does not improve or worsen after treatment [34].
In our study arterial blood gases analysis was done to about
17% of patients as it is not a routinely investigation to patient
with acute asthma. For example, arterial blood gas measure-
ment are helpful for evaluating PaCo2 in patient with sus-
pected hyperventilation, those with severe distress or those
with PEF 630% of predicted value after initial treatment [34].
The typical blood gases abnormalities seen in acute asthma
consist of combination of hypoxemia, hypocapnea and respira-
tory alkalosis. Generally the more severe the obstruction, the
lower the arterial oxygen tension (PaO2). Most asthma attacks
are not associated with marked hypoxemia and arterial desat-
uration, the average PaO2 is about 69 mmHg. Patient generally
hyperventilate, causing a reduction in PaCo2 (mean 34 mmHg).
Retention of Co2 is observed in about 10% of cases requesting
emergency care [9].
In our study three patients of 17 had PaCo2 >45 mmHg
with hypoxemia and respiratory acidosis and they admitted
to the ICU.
Therefore, hypercapnea during acute asthma attacks is a
sign of severe airﬂow obstruction but it does not always predict
the need for assisted ventilation. Because most exacerbations
of asthma are associated with hyperventilation causing hypoc-
apna and respiratory alkalosis, the ﬁnding of rising or normal
arterial or venous PaCO2 in the sitting of acute asthma should
be interpreted as a sign of impending respiratory failure and
the possible need for assisted ventilation if it persists or wors-
ens [42].
The blood gases levels either arterial or venous, should be
determined if the treating physician wishes to know the
PCO2 and pH, or spirometry or peak expiratory measure-
ments are either not available or not possible for a patient
whose condition is not improving or is deteriorating. Venous
gas measurement may be preferred over arterial blood gases
analysis because the venous sample can be drown by any
one skilled at venipuncture and is less painful for the pa-
tient. However, the venous PO2 and venous oxygen satura-
tion should be ignored, as they are not representative of
arterial values [43].
There were additional investigations such as chest radiog-
raphy and complete blood cell count, which were done to
some patient in the current study to exclude pneumothorax,
pnuemomediastinum, pneumonia and congestive heart
failure.
In GINA guidelines plain chest x-ray is not routinely re-
quired, but should be carried out if a complicated cardiopul-
monary process is suspected, in patients requiring
hospitalization, and in those not responding to treatment
where a pnuemothorax may be difﬁcult to diagnose clinically
[7]. A complete blood cell count is rarely needed, but might
be appropriate is patients with fever or purulent sputum, but
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mon in patients with asthma [2].
Optimum management of acute asthma in the emergency
department requires rapid access to facilities and personal
capable of delivering bronchodilators appropriately, obtaining
objective assessment of severity of the episode (by a peak ﬂow
meter), appropriately monitoring oxygen delivering and ensur-
ing safe disposition and referral of patient with asthma [34].
In the current study, we inserted intravenous line to all pa-
tients, assessed oxygenation continues by pulse oximetry be-
cause acute asthma is an unstable and unpredictable
condition, and objective measurement of lung function by
peak ﬂow meter was done and repeated every 30–60 min to
help guide therapy.
Then all the patients in ED were assisted to determine the
severity of asthma concomitant with administration of initial
treatment (plan A), which is oxygen to achieve O2 saturation
P92%, inhaled B2 adrenergic bronchodilator and an oral or
intravenous dose of corticosteroids if no immediate response,
if patient recently took oral glucocorticoides or the episode is
severe.
The rapidity of response to initial therapy, as deﬁned by
change in symptoms, signs and peak expiratory ﬂow, may be
a more useful measure of severity and the need for more
aggressive therapy than the clinical status at presentation [41].
After initial treatment, we found that:
- Five patients met a good response so they entered in (plan
C1).
- Seventy ﬁve patients met with the criteria of moderate epi-
sode they went to (plan B1), We found that 68 patients of
them (about 90%) had a good response within 2 h so went
to (plan C1), and the rest 7 patients (10%) had an incom-
plete response went to (plan C2).
- Twenty patients met with criteria of severe episode, 17 of
them (85%) with incomplete response moved to (plan
C2), and the rest 3 patients (15%) had a poor response
and moved to (plan C3), no improvement noticed so they
were admitted to the ICU.
- Hospitalization was done to 11 patients who met a poor
response (plan C2).
- Eighty-six patients were discharged from the ED (73
patients from plan C1, and 13 patients from plan C2).
There are many studies that approved the sequence therapy
in management of acute asthma exacerbation as in a study was
done by Rodrigo et al [44] who said that hypoxia is the main
cause of death in cases of acute asthma. Therefore oxygen
should be titrated to achieve oxygen saturation more than or
equal 92% and it should be monitored until a clear response
to bronchodilator therapy has occurred.
McFadden [9], said that all patient should receive inhaled
B2 agonist treatment because repetitive or continues adminis-
tration of these agents is the most effective measure of revers-
ing airﬂow obstruction.
Systemic glucocorticoides are recommended for most pa-
tients because they speed the resolution of airﬂow obstruction
and reduce the rate of post ED relapse, so in ED, systemic cor-
ticosteroids should be administered to all patients with moder-
ate to severe exacerbation and to those who do not respond to
initial B2 agonist therapy [8].Rodrigo and Castro Rodriguez [45] said that combination
of short acting and anti- cholinergic bronchodilator with short
acting B2 agonist has a greater improvement in lung function
and signiﬁcant reduction in the need for admission to hospital
than use of B2 adrenergic alone.
There is no support for routine use of intravenous magne-
sium sulfate for acute asthma, but there is evidence that it is
effective for patients with no response to ﬁrst line initial ther-
apy and those with initial severe airﬂow obstruction (PEF<
30% predicted) [46].
Aminophylline is not recommended for acute asthma, as a
systematic reviews have consistently concluded that it confer
no additional beneﬁt over B2 adrenergic bronchodilator, in
addition this drug has a narrow therapeutic margin and can
cause substantial toxic effects especially among toxic patients
[47].
Both clinical and lung function are used in making the deci-
sion to admit patient to hospital. Patients who continue to ex-
hibit indication of severe asthma despite two to three hours of
aggressive treatment should probably be hospital admitted
[34].
As we mentioned before that 11 patients were admitted to
hospital word. They were aggressively treated in ED for more
than 3 h with incomplete response to treatment. Their PEF
was <40% of predicted. This matched with what was said
by Aldington and Beasly [40], that patients who present with
pretreatment PEF <30% of predicted and those with value
after treatment that are <40% of predicted should usually
be admitted to hospital.
Stay in ED depends on the severity of current attack. In this
study the relation between severity of current attack and stay
in ED by hours showed that the mean of stay in ED (hours)
was 2.25 ± 1.037 and 5.38 ± 2.605 h for mild to moderate
and severe to life threatening groups respectively. Severe to life
threatening group have stay in ED higher than mild group.
(P= 0.0001). Therefore, the longer stay in ED, the higher
indication for hospital admission [34].
Although most patients respond well to therapy; a small
percentage (3%) showed signs of worsening ventilation include
inability to speak, altered mental status, worsening fatigue and
Paco2 P42 mmHg, and they were intubated in ED and trans-
ferred to the ICU.
The study done by Camegro et al [38] recommended that
patients presented with persistent or increasing hypercapnea,
exhaustion and depressed mental status, strongly suggest the
need for ventilator support. Two issued must be considered
at the time of intubation, ﬁrst, intravenous volume should be
maintained or replaced because hypotension commonly
accompanies the initiation of positive pressure ventilation. In
addition, high ventilation pressure with their risks of barotrau-
mas should be avoided.
In current study the follow up was performed to only 27
patients within two weeks after discharge from the ED by
telephone. Ten of them had a relapse although almost all
patients had medical advice before the ED discharge. The
incidence of relapse was high due to poor adherence with
medical advice that might be due to the cost of medications,
limited access to health care professionals, lack of educa-
tional sitting as smoking cessation and disconnection be-
tween ED staff and primary health care providers and
chest clinics.
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All patients presented to the emergency department with asth-
ma exacerbations should be evaluated and triaged immediately
and treated according to their severity of classiﬁcation using
GINA guidelines.
Patient presented with respiratory rate more than 25/min
should be assessed quickly to determine whether he/she has
any signs or symptoms of potentially fatal asthma and should
be immediately triaged to a closely monitored setting within
the emergency department.
Measurements of airﬂow obstruction, using peak expira-
tory ﬂow, can help to guide therapy for acute asthma because
both patients and physicians tend to inaccurately gauge the le-
vel of airﬂow obstruction that can lead to under treatment and
unacceptable risk of relapse. However, it generally underuti-
lized despite its ease of performance.
Continuous monitoring of oxyheamoglobin saturation by
transcutaneous pulse oximetry should be undertaken for all
patients with acute exacerbation of asthma and oxygen should
be administered to all patients with acute asthma exacerbation
to maintain their oxygen saturation P92%.
The emergency department is an important point of contact
between patients with asthma and their health care providers.
In the reality, unfortunately there is disconnection between ED
staff and primary health care providers and chest clinics. Such
problem leads to increase the rate of relapse, and the burden of
the problem. So efforts should be directed to ensure follow up
with health care providers and asthma specialist after visiting
emergency department for an exacerbation of asthma.
Recommendations
There were many obstacles in implementation of the GINA
guidelines in ED to asthmatic patients. There was a signiﬁcant
lack of documentation of features suggesting a need for in-
creased caution, such as history of hospitalization, mechanical
ventilation, previous or current need for corticosteroid therapy
and history of rapid worsening of asthma also a poor under-
standing of asthma and its therapy.
Therefore, we must;
– Educate patients in ED about the nature of asthma and its
therapy as the difference between reliever and controllers.
– Making patients identify the possible triggers that made the
asthma worsen.
– Educate patients how to use inhalers.
– Encourage patients to use spirometer at home and when
they should seek medical advice.
– Discharge each patient with ED-asthma discharge plan.
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